1. Home
  2. PDSB vs UG Comparison

PDSB vs UG Comparison

Compare PDSB & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • UG
  • Stock Information
  • Founded
  • PDSB 2005
  • UG 1942
  • Country
  • PDSB United States
  • UG United States
  • Employees
  • PDSB N/A
  • UG N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • UG Package Goods/Cosmetics
  • Sector
  • PDSB Health Care
  • UG Consumer Discretionary
  • Exchange
  • PDSB Nasdaq
  • UG Nasdaq
  • Market Cap
  • PDSB 58.7M
  • UG 50.1M
  • IPO Year
  • PDSB N/A
  • UG N/A
  • Fundamental
  • Price
  • PDSB $1.34
  • UG $10.50
  • Analyst Decision
  • PDSB Strong Buy
  • UG
  • Analyst Count
  • PDSB 3
  • UG 0
  • Target Price
  • PDSB $14.00
  • UG N/A
  • AVG Volume (30 Days)
  • PDSB 235.1K
  • UG 8.5K
  • Earning Date
  • PDSB 03-26-2025
  • UG 03-21-2025
  • Dividend Yield
  • PDSB N/A
  • UG 6.63%
  • EPS Growth
  • PDSB N/A
  • UG 38.11
  • EPS
  • PDSB N/A
  • UG 0.76
  • Revenue
  • PDSB N/A
  • UG $12,312,275.00
  • Revenue This Year
  • PDSB N/A
  • UG N/A
  • Revenue Next Year
  • PDSB N/A
  • UG N/A
  • P/E Ratio
  • PDSB N/A
  • UG $14.25
  • Revenue Growth
  • PDSB N/A
  • UG 11.51
  • 52 Week Low
  • PDSB $1.25
  • UG $7.02
  • 52 Week High
  • PDSB $6.68
  • UG $16.25
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 40.27
  • UG 44.74
  • Support Level
  • PDSB $1.41
  • UG $10.31
  • Resistance Level
  • PDSB $1.56
  • UG $11.08
  • Average True Range (ATR)
  • PDSB 0.14
  • UG 0.38
  • MACD
  • PDSB -0.00
  • UG -0.07
  • Stochastic Oscillator
  • PDSB 21.24
  • UG 23.85

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: